GLP-1 Drug Aleniglipron Shows Up to 11.3% Weight Loss in Phase 2b Trial
Aleniglipron, an oral GLP-1 drug, showed up to 11.3% weight loss in a phase 2b trial of 230 adults.
News on obesity, weight management and weight-loss medicines such as GLP-1 drugs.
Pasteurized Gut Bacterium Shows Promise for Weight-Loss Maintenance, Study Finds
Pasteurized Akkermansia muciniphila showed promise for weight-loss maintenance in a new randomized trial.
Tomato-Soy Juice Study Points to a Food-Based Way to Ease Inflammation in Obesity
A small study suggests tomato-soy juice may reduce inflammation markers in adults with obesity after four weeks.
NHS England Sets Out New Weight Management Service for 2025/26
NHS England updates its 2025/26 weight management service, highlighting primary care support for obesity and diet-related health.
Great Britain Study Finds Millions Using or Considering Weight-Loss Drugs
UCL research says millions in Great Britain are using or considering weight-loss drugs, raising equity and supervision concerns.
NICE Recommends Semaglutide Injection to Help Prevent Heart Attacks and Strokes in High-Risk Patients
NICE recommends semaglutide for high-risk cardiovascular patients, alongside diet and exercise, to help prevent heart attacks and strokes.
